Timing exercise relative to tirzepatide injections affects tolerability
A 2024 real-world evidence study (Lingvay et al., Obesity) compared outcomes for patients on semaglutide vs tirzepatide in a large U.S
This information helps you understand your natural metabolic tendencies after stopping medication, supporting personalized strategies for maintaining weight loss during your fertility journey and pregnancy preparation
To view or add a comment, sign in BREAKING: An FDA advisory committee voted to approve the peptide BPC-157 to be recommended for inclusion on the official compounding list
5, in Nature Medicine seems to back up the FDAs preliminary findings.[1] Rong Xu, PhD, a professor of biomedical informatics and director of the Center for AI in Drug Discovery at Case Western Reserve University, and colleagues examined data from more than 240,000 overweight or obese patients prescribed either semaglutide or non-GLP-1 receptor agonist anti-obesity medications
Better Mental Health Regular exercise aids in reducing stress and anxiety, which can contribute to emotional eating and weight gain